Gastroesophageal reflux disease in nurse practice

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Gastroesophageal reflux disease (GERD) is characterized by a large number of clinical manifestations, including asymptomatic and extraesophageal manifestations, so the interest in this nosology of doctors of various specialties is huge. Gastroesophageal reflux disease is considered by modern gastroenterologists as one of the most urgent problems of diseases of the digestive tract. The prevalence of GERD in Western Europe is 10–20%, in Russia – 22,7%, and in Moscow – 23,6% [1]. Studies show that the incidence of this pathology is steadily increasing (annual increase of about 5%). The importance of gastroesophageal reflux disease is determined by its clinical significance, in particular, the possibility of the existence of so-called extraesophageal manifestations, as well as the lack of effectiveness of existing methods of treatment. All this causes close attention of gastroenterologists to the study of pathophysiological and clinical problems of gastroesophageal reflux disease.

Full Text

Restricted Access

About the authors

Vsevolod V. Skvortsov

Federal State Budgetary Educational Institution of Higher Education «Volgograd state medical university» of the ministry of health of the Russian Federation

Author for correspondence.
Email: vskvortsov1@ya.ru
ORCID iD: 0000-0002-2164-3537

Doctor of Medicine, Associate Professor of the Department of Internal Medicine

Russian Federation, Volgograd

Aleksandr V. Morozov

Federal State Budgetary Educational Institution of Higher Education «Volgograd state medical university» of the ministry of health of the Russian Federation

Email: utrotv@mail.ru

5th year student of Faculty of General Medicine

Russian Federation, Volgograd

References

  1. Маев И.В., Бакулин И.Г., Бакулина Н.В. и др. Клинико-эндоскопические характеристики ГЭРБ у пациентов с ожирением // Эффективная фармакотерапия. 2021. Т. 17. № 4. С. 12–20.
  2. Ивашкин В.Т., Маев И.В., Трухманов А.С., Лапина Т.Л., Сторонова О.А., Зайратьянц О.В., Дронова О.Б., Кучерявый Ю.А., Пирогов С.С., Сайфутдинов Р.Г., Успенский Ю.П., Шептулин А.А., Андреев Д.Н., Румянцева Д.Е. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению гастроэзофагеальной рефлюксной болезни. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2020;30(4):70-97. https://doi.org/10.22416/1382-4376-2020-30-4-70-97
  3. Зверева, С.И., Еремина, Е.Ю. Гастроэзофагеальная рефлюксная болезнь / С.И. Зверева, Е.Ю. Еремина. Исток-система Гастро-Скан [Электронный ресурс]. www.gastroscan.ru.
  4. Аруин Л.И., Исаков В.А. Гастроэзофагеальная рефлюксная болезнь и Helicobacter pylori. Клин. медицина. 2000; (10): 62–68.
  5. Кононов А.В. Гастроэзофагеальная рефлюксная болезнь: взгляд морфолога на проблему. Рос. журн. гастроэнтерологии, гепатологии и колопроктологии. 2004; 14 (1): 71–77.
  6. Калягин А.Н., Аснер Т.В. Гевискон в ведении больных с внепищеводными проявлениями гастроэзофагеальной рефлюксной болезни. Гастроэнтерология. Приложение к журналу Consilium Medicum. 2013; (1): 14–17.
  7. Boeckxstaens, G., El-Serag, H. Republished: Symptomatic reflux disease: the present, the past and the future/ G. Boeckxstaens, H. El-Serag. Postgrad. Med. J. 2015; (91): 46–54.
  8. Ткач С.М. Ведение больных гастроэзофагеальной болезнью в свете последнего американского консенсуса. Гастроэнтерология. 2013; (2): 108–113.
  9. Peters Y, Al-Kaabi A, Shaheen NJ, Chak A, Blum A, Souza RF, Di Pietro M, Iyer PG, Pech O, Fitzgerald RC, Siersema PD. Barrett oesophagus. Nat Rev Dis Primers. 2019 May 23;5(1):35. doi: 10.1038/s41572-019-0086-z. PMID: 31123267.
  10. Rubenstein J.H., Scheiman J.M., Sadeghi S., et al. Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies. Am. J.Gastroenterol. 2013; (106): 254–260.
  11. Гончар Н.В. Гастроэзофагеальная рефлюксная болезнь у детей (клиника и терапия): автореф. дис. д-ра мед. наук. СПб., 2004.
  12. C.A. Fallone, A.N. Barkun, G. Friedman. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am. J. Gastroenterol. 2000; (95): 914 – 920.
  13. Fass R, Boeckxstaens GE, El-Serag H, Rosen R, Sifrim D, Vaezi MF. Gastro-oesophageal reflux disease. Nat Rev Dis Primers. 2021 Jul 29;7(1):55. doi: 10.1038/s41572-021-00287-w. PMID: 34326345.
  14. Shaheen NJ, Falk GW, Iyer PG, Souza RF, Yadlapati RH, Sauer BG, Wani S. Diagnosis and Management of Barrett’s Esophagus: An Updated ACG Guideline. Am J Gastroenterol. 2022 Apr 1;117(4):559-587. doi: 10.14309/ajg.0000000000001680. PMID: 35354777; PMCID: PMC10259184.
  15. Maev I.V., Bakulin I.G., Bakulina N.V. and others. Clinical and endoscopic characteristics of GERD in obese patients // Effective pharmacotherapy. 2021. T. 17. № 4. pp. 12–20.
  16. Ivashkin V.T., Maev I.V., Trukhmanov A.S., Lapina T.L., Storonova O.A., Zayratyants O.V., Dronova O.B., Kucheryavyy Yu.A., Pirogov S.S., Sayfutdinov R.G., Uspenskiy Yu.P., Sheptulin A.A., Andreev D.N., Rumyantseva D.E. Recommendations of the Russian Gastroenterological Association in Diagnosis and Treatment of Gastroesophageal Reflux Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020;30(4):70-97. (In Russ.) https://doi.org/10.22416/1382-4376-2020-30-4-70-97
  17. Zvereva, S.I., Yeremina, E.Yu. Gastroesophageal reflux disease / S.I. Zvereva, E.Yu. Eremina. Istok-sistema Gastro-Scan [Electronic resource]. www.gastroscan.ru.
  18. Aruin L.I., Isakov V.A. Gastroesophageal reflux disease and Helicobacter pylori. Clin. med. 2000; (10): 62–68.
  19. Kononov A.V. Gastroesophageal reflux disease: a morphologist’s view of the problem. Ross. magazine gastroenterology, hepatology and coloproctology. 2004; 14(1):71–77.
  20. Kalyagin A.N., Asner T.V. Gaviscon in management of patients with extrasesophageal manifestations of gastroesophageal reflux disease. Gastroenterology. Appendix to the journal Consilium Medicum. 2013; (1): 14–17.
  21. Boeckxstaens, G., El-Serag, H. Republished: Symptomatic reflux disease: the present, the past and the future/ G. Boeckxstaens, H. El-Serag. Postgrad. Med. J. 2015; (91): 46–54.
  22. Tkach S.M. Management of patients with gastroesophageal disease in light of the latest American consensus. Gastroenterology. 2013; (2): 108–113.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. Endoscopic classification of reflux esophagitis (RE) severity according to Savary–Miller.

Download (291KB)
Indexing metadata

Copyright (c) 2024 Russkiy Vrach Publishing House